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Background: Birth defects are disproportionately higher among certain race/ethnic groups.
We examined how birth defects prevalence differs among the less studied non-Hispanic (NH)
Asian and any American Indian/Alaska Native (AI/AN) populations, relative to NH Whites.
Methods: Data were obtained from the Texas Birth Defect Registry from 1999 to 2015 for
infants born to Texas-resident mothers who were NH White, NH Asian, or AI/AN. This
covers a livebirth population of 2.6 million. Prevalence ratios were calculated for NH Asians
and AI/ANs (relative to NH Whites) for 44 birth defects using Poisson regression and were
adjusted for maternal age.
Results: After adjustment, there were 34 statistically significant prevalence ratios. Among
NH Asians, 23 defects had a lower adjusted prevalence ratio (aPR) and 3 defects had a higher
aPR. AI/ANs had 2 defects with a significantly lower aPR and 6 with a higher aPR.
Conclusions: NH Asians generally have a lower prevalence for birth defects while AI/ANs
have a higher prevalence compared to NH Whites. These findings update the limited
previous literature on this topic and also warrant additional research among larger
populations in order to identify the true association of these understudied race/ethnic groups.

TABLE OF CONTENTS
List of Tables ............................................................................................................................. i
Background ................................................................................................................................1
Literature Review.................................................................................................................1
Public Health Significance ...................................................................................................3
Specific Aims .......................................................................................................................4
Methods......................................................................................................................................4
Dataset4
Outcome ...............................................................................................................................5
Data Analysis .......................................................................................................................6
Results ........................................................................................................................................8
Discussion ................................................................................................................................15
Conclusion ...............................................................................................................................18
References ................................................................................................................................20

LIST OF TABLES
Table 1: Birth Defects Examined, Texas BDR, 1999-2015......................................................7
*defect was not previously examined in national studies15,16 ....................................................8
Table 2: Prevalence of Selected Birth Defects Among Maternal Racial/Ethnic
Groups, Texas, 1999-2015 .....................................................................................11
Table 3. Adjusted Prevalence Ratios of Selected Birth Defects Among Maternal
Racial/Ethnic Groups, Texas, 1999-2015 ..............................................................14

i

BACKGROUND
Literature Review
In the United States (U.S.), birth defects affect 1 in every 33, or 3.0%, of all live
births.1 Birth defects are common and are the leading cause of infant mortality. In 2016, the
Centers for Disease Control and Prevention (CDC) reported that birth defects accounted for
20.8% off all infant deaths.3 Infant mortality can be used as a predictor of overall health in a
given population. As birth defects are the number one cause of infant death in the U.S., it is
important to better understand the underlying causes, risk factors for, and strategies for
preventing them.
In Texas, the overall prevalence of birth defects is 4.7%, which is higher compared to
the national percent prevalence.2 The infant mortality rate in the U.S. as a whole is 5.9 per
1,000 live births.3 Among the 50 states in the U.S., Texas has the 32nd highest infant
mortality rate— with a rate of 5.7 per 1,000 live births.4 These statistics provide evidence
that Texas measures similarly to nationwide values. Consequently, studies of birth defects in
Texas may be helpful in providing a framework for developing future studies incorporating
data from other regions of the U.S.
Birth defects are disproportionally associated with specific racial/ethnic groups. One
of the most commonly studied associations is the increased prevalence of neural tube defects
(NTDs) among Hispanics.5 Further, race/ethnicity groups often examined in birth defect
analyses are typically limited to non-Hispanic (NH) Whites, NH Blacks, and Hispanics.6-9
Minority groups such as Asians and American Indians/Alaska Natives (AI/ANs) generally
make up a small proportion of the population in comparison to other race/ethnicity groups,
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making it difficult to conduct meaningful subgroup analyses. Researchers, therefore, have
frequently ignored these groups or lumped them into an “Other” category to increase sample
size and power. When this is done, however, important differences with respect to culture,
environment, and genetic makeup are missed. Cultural and environmental differences
between race/ethnicity groups point to potential differences in socioeconomic status— a
factor also associated with varying environmental exposures, access to care issues, low
maternal educational attainment, and barriers to services.10
In addition to cultural and environmental factors, genetics also play a role in birth
defect outcomes. Research on birth defects and genetics, however, is incomplete due to its
complex nature.11 Various studies have shown that individuals with similar biogeographical
ancestry, which can be categorized broadly by race/ethnicity, have a similar genetic
makeup.12 Therefore, it is important to examine specific groupings rather than the more
homogeneous “Other” category, to fully elucidate these differences.
According to data from the U.S. Census Bureau, Asians were the fastest growing
racial/ethnic group in the U.S. during the period of 2000 to 2010, increasing 43% during this
time.13 Similarly, the AI/AN population also experienced a 39% growth.14 Although these
two populations are among the fastest growing in the U.S., little is known about the
occurrence and etiology of birth defects with reference to these groups.
In a previous study using pooled data from 12 population-based state birth defects
surveillance systems in the U.S., Canfield et al. (2014), provided prevalence data for selected
birth defects among 5 racial/ethnic groups, including Asians and AI/AN.15 Analyses were
conducted for infants born from 1999 to 2007. Results of this study showed a higher
2

prevalence for selected birth defects for AI/ANs and a lower prevalence among Asians.
Marengo et al. (2018) further studied birth defect prevalence in the AI/AN population
incorporating additional covariates.16 The results of this study showed that higher prevalence
remained for two birth defects even after adjustment. To build on these findings, the present
study included more recent data for analyses from 1999 through 2015 birth year in Texas,
and considered an important covariate, maternal age. Currently, there are no studies on the
prevalence of birth defects among Asian and AI/AN race/ethnicity groups for this extended
period in Texas, including data from recent years.

Public Health Significance
Infant mortality can be used as a proxy for a nation’s health and is a commonly used
proxy measure worldwide.17 This measure is highly regarded because there are many
contributing factors including those related to maternal health, access to care, socioeconomic
factors, and environmental health. In a report conducted by MacDorman et al. (2010), the
U.S. ranked 26th out of the 29 European countries in the Organisation for Economic Cooperation and Development (OECD) database.17 Although a developed country, the U.S.
ranks behind many developing nations. In order to reduce the nation’s infant mortality rate, it
is important to recognize that birth defects are the most common cause of infant mortality in
the U.S.
While birth defects as a whole are somewhat common occurrences, individual birth
defects can be quite rare. Moreover, each birth defect has its own unique etiology and
mortality profile. Since there is high variation from one defect to another, the causes are
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largely unknown. Feldkamp et al. (2017), conducted a five-year population-based study to
assess the causes of birth defects that are monitored in Utah’s birth defect surveillance
system.18 The results showed that only 20% of birth defects had a known etiology,
underscoring the fact that there are large gaps in the literature regarding birth defects. In
order to create effective interventions to reduce the largest contributor to infant mortality, it
is important to first understand what causes birth defects and their associated risk factors.
Thus the specific aims of this research are:

Specific Aims
1. To describe the prevalence of 44 selected birth defects among non-Hispanic (NH)
Whites, NH Asians, and American Indians/Alaskan Natives (AI/ANs) in Texas from
1999 to 2015.
2. To determine the unadjusted associations between NH Asian or AI/AN (regardless of
Hispanic ethnicity) and selected birth defects, relative to NH Whites.
3. To describe the relationship between NH Asians or AI/ANs and selected birth
defects, relative to NH Whites, with adjustment for maternal age.

METHODS
Dataset
In this study we used data from the Texas Birth Defects Registry (BDR). The Texas
BDR is an active surveillance system that is population-based and maintained by Texas
4

Department of State Health Services (DSHS) Birth Defects Epidemiology and Surveillance
(BDES) Branch. Statewide data became available in the Texas BDR in 1999 and includes
complete data up to 2015. This study included complete data on infants born from 1999 to
2015 (regardless of pregnancy outcome) and whose mothers were residents of Texas at the
time of delivery. Data used in this analysis were de-identified line-item data for both birth
defects and birth records.

Outcome
Infants included in the study were diagnosed with at least one or more of 44 selected
birth defects within the first year of life. The birth defects considered for analyses in this
study were based on defects that were reported and published for the National Birth Defects
Prevention Network (NBDPN) Annual Report. The following broad organ systems or
categories were included: central nervous system, ear/eye, cardiovascular, orofacial,
gastrointestinal, genitourinary, musculoskeletal, and chromosomal defects (see Table 1 for
specific defect breakdowns). Twenty of the 44 defects were not previously examined in the
national studies on birth defects and race/ethnicity. If an infant was diagnosed with multiple
birth defects, each occurrence of the defect was counted in each birth defect category.
The NBDPN was used as guidance for the selection of birth defects to be included in
this study because it is widely referred to by public health officials, researchers, and families
for its high standards in birth defect surveillance.19 By combining data from several state and
population-based surveillance systems, studies using the NBDPN data are able to have higher
statistical power, which enables researchers to study rare birth defects and diverse
5

populations. Numerous publications on birth defects have been developed from the NBDPN
data; therefore, using similar defects as those reported to the NBDPN allow for greater
comparability with the results to existing work.

Data Analysis
Birth record data were obtained from the Texas DSHS Center for Health Statistics
(CHS). Birth records are routinely linked to birth defect cases in the Texas BDR in order to
gain maternal sociodemographic data for cases, such as maternal race/ethnicity and maternal
age. Maternal race/ethnicity was categorized into the following categories: NH White, NH
Asian, and any American Indian/Alaska Native. NH Blacks and Hispanics were excluded
from this study. Race/ethnicity classification were based on vital records. Individuals were
grouped by Hispanic ethnicity then by race. Additionally, NH Asians and AI/ANs who were
misclassified in the “Other” race/ethnic category were corrected based on the “Other” race
description field from the vital records. Because NH Asians and AI/ANs were the
populations of interest, the data for NH Whites were not similarly corrected. As an aside, NH
Asians and AI/ANs were not further stratified into specific subgroups due to the small
population size. Records of mothers who were of multiple race/ethnicities or had that
variable missing were excluded from the study.
Birth defect prevalence were calculated by dividing cases of birth defects (of any
pregnancy outcome) by the number of live births, in terms of cases per 10,000 live births.
Live birth denominators are commonly used in birth defects epidemiology, even when nonlive cases are included in the numerator. Additionally, 95% confidence intervals (CIs) also
6

were calculated for each birth defect prevalence estimate. Birth defect prevalence was
calculated for NH Whites alone, NH Asians alone, and any AI/AN alone. Poisson regression
was used to calculate crude and adjusted prevalence ratios (aPRs) for each race/ethnic group,
adjusting for maternal age (<20, 20-34, 35+ years). NH Whites served as the referent group.
Crude prevalence ratios were not shown in the final results because the measures were
similar to that of the aPRs. The 95% CIs were also provided with the aPRs following a
Poisson distribution. These calculations were performed using SAS statistical software,
version 9.4.

Table 1: Birth Defects Examined, Texas BDR, 1999-2015
Central Nervous System
Anencephalus
Spina bifida without anencephalus
Encephalocele
Holoprosencephaly*
Ear/Eye
Anophthalmia/microphthalmia*
Congenital cataract
Anotia/microtia
Cardiovascular
Aortic valve stenosis
Common truncus (truncus arteriosus)
Transposition of great arteries (TGA)
Ventricular septal defect
Atrial septal defect*
Atrioventricular septal defect (endocardial cushion defect)
Pulmonary valve atresia and stenosis*
Tricuspid valve atresia and stenosis*
Ebstein's anomaly*
Hypoplastic left heart syndrome*
Coarctation of aorta
Total anomalous pulmonary venous connection*
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Single ventricle*
Interrupted aortic arch*
Orofacial
Cleft palate alone
Cleft lip alone
Cleft lip with cleft palate
Choanal atresia*
Gastrointestinal
Esophageal atresia/ tracheoesophageal fistula
Rectal and large intestinal atresia/stenosis
Biliary atresia*
Small intestinal atresia/stenosis*
Genitoururinary
Renal agenesis/hypoplasia*
Bladder exstrophy*
Hypospadias
Congenital posterior urethral valves*
Musculoskeletal
Gastroschisis
Omphalocele
Diaphragmatic hernia
Limb deficiencies (reduction defects)
Craniosynostosis*
Clubfoot*
Chromosomal
Trisomy 13
Trisomy 21 (Down syndrome)
Trisomy 18
Turner syndrome*
Deletion 22q11.2*
*defect was not previously examined in national studies15,16

RESULTS
This study included 75,960 cases of the selected birth defects that were either cooccurring or isolated defects among NH Whites, NH Asians, and any AI/AN. There were
8

2,586,306 in the livebirth population, which accounts for approximately 40% of all livebirths
in Texas from 1999 to 2015. Table 2 shows the prevalence and the 95% CIs for the 44 birth
defects. This table shows prevalences for the total study population and for the 3 mutually
exclusive race/ethnic groups: NH White, NH Asian, and any AI/AN. The least prevalent birth
defects among NH Asians were bladder exstrophy, deletion 22q11.2, and common truncus.
For both NH Asians and AI/ANs, the most prevalent defects were hypospadias, atrial septal
defect, and ventricular septal defect. Among only AI/ANs, the least prevalent birth defects
were trisomy 13, choanal atresia, and common truncus. However there were 3 defects with 0
cases among the AI/AN population: Turner syndrome, interrupted aortic arch, and bladder
exstrophy. Also note that approximately half of the prevalences among AI/ANs were based
on 5 or less cases.
Table 3 displays the aPRs and 95% CIs for NH Asians and any AI/ANs, relative to
NH Whites. Based on only statistically significant findings, NH Asians had a 50% or lower
prevalence for spina bifida without anencephalus (aPR= 0.38; 95% CI= 0.25-0.54),
craniosynostosis (aPR= 0.42; 95% CI= 0.39-0.46), and hypoplastic left heart syndrome
(aPR= 0.46; 95% CI= 0.29-0.67), compared to NH Whites. Lower prevalence ratios were
also noted for aortic valve stenosis (aPR= 0.54; 95% CI= 0.31-0.88), choanal atresia (aPR=
0.54; 95% CI= 0.35-0.79), and esophageal atresia/tracheoesophageal fistula (aPR= 0.55; 95%
CI= 0.31-0.89). Furthermore, NH Asians were found to have significantly higher prevalence
rates for 3 defects: biliary atresia (aPR= 2.50, 95% CI= 2.06-3.01), total anomalous
pulmonary venous connection (aPR= 1.36, 95% CI= 1.07-1.71), and anotia/microtia (aPR=
1.19, 95% CI= 1.14-1.24).
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Among AI/ANs, only two defects had a statistically significantly lower aPR
compared to NH Whites. These defects were hypoplastic left heart syndrome (aPR= 0.52,
95% CI= 0.23-0.98) and hypospadias (aPR= 0.64, 95% CI= 0.45-0.88). Defects with a
greater than 3-fold increased risk among AI/AN included biliary atresia (aPR= 4.63, 95%
CI= 1.62-10.22), anotia/microtia (aPR= 3.27, 95% CI= 1.97-5.05), and holoprosencephaly
(aPR= 3.05, 95% CI= 1.04-6.8). Additionally, elevated aPRs were observed for cleft lip with
cleft palate (aPR= 2.68; 95% CI= 1.91-3.64), clubfoot (aPR= 1.48; 95% CI= 1.03-2.04), and
esophageal atreasia/tracheoesophageal fistula (aPR= 1.36; 95% CI= 1.04-1.75). Although
statistically significant, some of these results are based on small numbers, for example the
high aPR seen for biliary atresia was based on only 4 cases in AI/ANs.
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Table 2: Prevalence of Selected Birth Defects Among Maternal Racial/Ethnic Groups, Texas, 1999-2015
Total

Non-Hispanic White

Non-Hispanic Asian

Any AI/AN

n

Prevalence
(95% CI)

n

Prevalence
(95% CI)

n

Prevalence
(95% CI)

n

Prevalence
(95% CI)

Anencephalus

496

1.92 (1.75-2.09)

448

1.94 (1.76-2.12)

43

1.67 (1.21-2.26)

5

3.29 (1.07-7.69)

Spina bifida without anencephalus

827

3.2 (2.98-3.42)

788

3.40 (3.17-3.64)

33

1.28 (0.88-1.80)

6

3.95 (1.45-8.61)

Encephalocele

184

0.71 (0.61-0.81)

161

0.70 (0.59-0.80)

21

0.82 (0.51-1.25)

2

1.32 (0.16-4.76)

Holoprosencephaly

215

0.83 (0.72-0.94)

194

0.84 (0.72-0.96)

17

0.66 (0.39-1.06)

4

2.64 (0.72-6.75)

Anophthalmia/microphthalmia

720

2.78 (2.58-2.99)

659

2.85 (2.63-3.06)

53

2.06 (1.55-2.70)

8

5.27 (2.28-10.39)

Congenital cataract

475

1.84 (1.67-2)

442

1.91 (1.73-2.09)

31

1.21 (0.82-1.71)

2

1.32 (0.16-4.76)

Anotia/microtia

545

2.11 (1.93-2.28)

472

2.04 (1.86-2.22)

63

2.45 (1.89-3.14)

10

6.59 (3.16-12.12)

Common truncus (truncus arteriosus)

161

0.62 (0.53-0.72)

150

0.65 (0.54-0.75)

10

0.39 (0.19-0.72)

1

0.66 (0.02-3.67)

Transposition of great arteries (TGA)

1250

4.83 (4.57-5.1)

1131

4.89 (4.6-5.17)

108

4.21 (3.41-5)

11

7.25 (3.62-12.97)

Ventricular septal defect

13505

52.22 (51.34-53.1)

12220

52.8 (51.87-53.74)

1203

46.84 (44.2-49.49)

82

54.04 (42.98-67.07)

Atrial septal defect

15749

60.89 (59.94-61.84)

14301

61.79 (60.78-62.81)

1357

52.84 (50.03-55.65)

91

59.97 (48.28-73.63)

1176

4.55 (4.29-4.81)

1093

4.72 (4.44-5)

77

3 (2.37-3.75)

6

3.95 (1.45-8.61)

Birth Defect
Central Nervous System

Ear/Eye

Cardiovascular

Atrioventricular septal defect
(endocardial cushion defect)
Pulmonary valve atresia and stenosis

2166

8.37 (8.02-8.73)

1986

8.58 (8.2-8.96)

163

6.35 (5.37-7.32)

17

11.2 (6.53-17.94)

Tricuspid valve atresia and stenosis

437

1.69 (1.53-1.85)

387

1.67 (1.51-1.84)

48

1.87 (1.38-2.48)

2

1.32 (0.16-4.76)

Ebstein's anomaly

179

0.69 (0.59-0.79)

159

0.69 (0.58-0.79)

18

0.7 (0.42-1.11)

2

1.32 (0.16-4.76)

Aortic valve stenosis

681

2.63 (2.44-2.83)

638

2.76 (2.54-2.97)

39

1.52 (1.08-2.08)

4

2.64 (0.72-6.75)

Hypoplastic left heart syndrome

625

2.42 (2.23-2.61)

593

2.56 (2.36-2.77)

30

1.17 (0.79-1.67)

2

1.32 (0.16-4.76)

Coarctation of aorta

1419

5.49 (5.2-5.77)

1312

5.67 (5.36-5.98)

99

3.85 (3.13-4.69)

8

5.27 (2.28-10.39)

Total anomalous pulmonary venous

314

1.21 (1.08-1.35)

270

1.17 (1.03-1.31)

41

1.6 (1.15-2.17)

3

1.98 (0.41-5.78)

11

connection
Single ventricle

195

0.75 (0.65-0.86)

179

0.77 (0.66-0.89)

14

0.55 (0.3-0.91)

2

1.32 (0.16-4.76)

Interrupted aortic arch

147

0.57 (0.48-0.66)

136

0.59 (0.49-0.69)

11

0.43 (0.21-0.77)

0

-

Cleft lip alone

1702
1008

6.58 (6.27-6.89)
3.9 (3.66-4.14)

1523
920

6.58 (6.25-6.91)
3.98 (3.72-4.23)

170
81

6.62 (5.62-7.61)
3.15 (2.5-3.92)

9
7

5.93 (2.71-11.26)
4.61 (1.85-9.5)

Cleft lip with cleft palate

1828

7.07 (6.74-7.39)

1624

7.02 (6.68-7.36)

175

6.81 (5.8-7.82)

29

19.11 (12.8-27.45)

361

1.4 (1.25-1.54)

339

1.46 (1.31-1.62)

21

0.82 (0.51-1.25)

1

0.66 (0.02-3.67)

604

2.34 (2.15-2.52)

564

2.44 (2.24-2.64)

35

1.36 (0.95-1.9)

5

3.29 (1.07-7.69)

1293

5 (4.73-5.27)

1173

5.07 (4.78-5.36)

110

4.28 (3.48-5.08)

10

6.59 (3.16-12.12)

174
788

0.67 (0.57-0.77)
3.05 (2.83-3.26)

133
730

0.57 (0.48-0.67)
3.15 (2.93-3.38)

37
54

1.44 (1.01-1.99)
2.1 (1.58-2.74)

4
4

2.64 (0.72-6.75)
2.64 (0.72-6.75)

Renal agenesis/hypoplasia

1475

5.7 (5.41-5.99)

1330

5.75 (5.44-6.06)

134

5.22 (4.33-6.1)

11

7.25 (3.62-12.97)

Bladder exstrophy

77
10639

0.3 (0.23-0.37)
80.18 (78.66-81.71)

73
9802

0.32 (0.25-0.4)
82.61 (80.97-84.24)

4
796

0.16 (0.04-0.4)
60.07 (55.90-64.25)

0
41

52.69 (37.81-71.47)

267

1.03 (0.91-1.16)

236

1.02 (0.89-1.15)

29

1.13 (0.76-1.62)

2

1.32 (0.16-4.76)

Gastroschisis

1234

4.77 (4.51-5.04)

1164

5.03 (4.74-5.32)

59

2.3 (1.75-2.96)

11

7.25 (3.62-12.97)

Omphalocele

549

2.12 (1.95-2.3)

499

2.16 (1.97-2.35)

44

1.71 (1.24-2.3)

6

3.95 (1.45-8.61)

Diaphragmatic hernia
Limb deficiencies (reduction defects)

700
1404

2.71 (2.51-2.91)
5.43 (5.14-5.71)

644
1298

2.78 (2.57-3)
5.61 (5.3-5.91)

53
87

2.06 (1.55-2.7)
3.39 (2.71-4.18)

3
19

1.98 (0.41-5.78)
12.52 (7.54-19.55)

Craniosynostosis

1644

6.36 (6.05-6.66)

1560

6.74 (6.41-7.08)

76

2.96 (2.33-3.7)

8

5.27 (2.28-10.39)

Clubfoot

4098

15.84 (15.36-16.33)

3815

16.48 (15.96-17.01)

246

9.58 (8.38-10.78)

37

24.38 (17.17-33.61)

Orofacial Clefts
Cleft palate alone

Gastrointestinal
Choanal atresia
Esophageal atresia/ tracheoesophageal
fistula
Rectal and large intestinal
atresia/stenosis
Biliary atresia
Small intestinal atresia/stenosis
Genitourinary

Hypospadias
Congenital posterior urethral valves
Musculoskeletal

12

Chromosomal
Trisomy 13

304

1.18 (1.04-1.31)

264

1.14 (1-1.28)

39

1.52 (1.08-2.08)

1

0.66 (0.02-3.67)

Trisomy 21 (Down syndrome)

3193

12.35 (11.92-12.77)

2891

12.49 (12.04-12.95)

287

11.18 (9.88-12.47)

15

9.88 (5.53-16.3)

Trisomy 18

639

2.47 (2.28-2.66)

561

2.42 (2.22-2.62)

74

2.88 (2.26-3.62)

4

2.64 (0.72-6.75)

Turner syndrome

274

2.18 (1.92-2.43)

255

2.26 (1.98-2.54)

19

1.53 (0.92-2.39)

0

-

Deletion 22q11.2

115

0.44 (0.36-0.53)

103

0.45 (0.36-0.53)

10

0.39 (0.19-0.72)

2

1.32 (0.16-4.76)

Note: AI/AN= American Indian/Alaska Native; CI= confidence interval
Hypospadias restricted to males
Turner syndrome restricted to females
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Table 3. Adjusted Prevalence Ratios of Selected Birth Defects Among Maternal
Racial/Ethnic Groups, Texas, 1999-2015

Birth Defect
Central Nervous System
Anencephalus
Spina bifida without anencephalus
Encephalocele
Holoprosencephaly
Ear/Eye
Anophthalmia/microphthalmia
Congenital cataract
Anotia/microtia
Cardiovascular
Common truncus (truncus arteriosus)
Transposition of great arteries (TGA)
Ventricular septal defect
Atrial septal defect
Atrioventricular septal defect
(endocardial cushion defect)
Pulmonary valve atresia and stenosis
Tricuspid valve atresia and stenosis
Ebstein's anomaly
Aortic valve stenosis
Hypoplastic left heart syndrome
Coarctation of aorta
Total anomalous pulmonary venous
connection
Single ventricle
Interrupted aortic arch
Orofacial Clefts
Cleft palate alone
Cleft lip alone
Cleft lip with cleft palate
Gastrointestinal
Choanal atresia
Esophageal atresia/ tracheoesophageal fistula
Rectal and large intestinal atresia/stenosis

Non-Hispanic Asians
Adjusted PR
n
(95% CI)

n

Any AI/AN
Adjusted PR
(95% CI)

43
33
21
17

0.89 (0.47-1.53)
0.38 (0.25-0.54)
1.18 (0.84-1.62)
0.83 (0.35-1.65)

5
6
2
4

1.67 (0.55-3.77)
1.17 (0.6-2.01)
1.89 (0.76-3.81)
3.05 (1.04-6.8)

53
31
63

0.69 (0.48-0.97)
0.63 (0.47-0.83)
1.19 (1.14-1.24)

8
2
10

1.9 (0.8-3.75)
0.69 (0.01-4.06)
3.27 (1.97-5.05)

10
108
1203
1357

0.58 (0.43-0.75)
0.83 (0.71-0.97)
0.86 (0.83-0.89)
0.84 (0.76-0.92)

1
11
82
91

1.05 (0.43-2.08)
1.52 (0.83-2.5)
1.04 (0.98-1.11)
0.98 (0.81-1.17)

77

0.58 (0.3-1)

6

0.89 (0.47-1.5)

163
48
18
39
30
99

0.73 (0.56-0.94)
1.11 (0.8-1.5)
1 (0.77-1.29)
0.54 (0.31-0.88)
0.46 (0.29-0.67)
0.66 (0.62-0.7)

17
2
2
4
2
8

1.31 (1-1.69)
0.79 (0-7.24)
1.93 (0.71-4.11)
0.96 (0.46-1.75)
0.52 (0.23-0.98)
0.94 (0.52-1.55)

41

1.36 (1.07-1.71)

3

1.69 (0.64-3.56)

14
11

0.69 (0.36-1.18)
0.71 (0.59-0.85)

2
0

1.74 (0.87-3.07)
-

170
81
175

1 (0.9-1.11)
0.81 (0.54-1.15)
0.99 (0.79-1.22)

9
7
29

0.9 (0.33-1.92)
1.15 (0.58-2.02)
2.68 (1.91-3.64)

21
35
110

0.54 (0.35-0.79)
0.55 (0.31-0.89)
0.84 (0.77-0.92)

1
5
10

0.46 (0-4.57)
1.36 (1.04-1.75)
1.3 (0.74-2.09)
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Biliary atresia
Small intestinal atresia/stenosis
Genitourinary
Renal agenesis/hypoplasia
Bladder exstrophy
Hypospadias
Congenital posterior urethral valves
Musculoskeletal
Gastroschisis
Omphalocele
Diaphragmatic hernia
Limb deficiencies (reduction defects)
Craniosynostosis
Clubfoot
Chromosomal
Trisomy 13
Trisomy 21 (Down syndrome)
Trisomy 18
Turner syndrome
Deletion 22q11.2

37
54

2.5 (2.06-3.01)
0.67 (0.51-0.86)

4
4

4.63 (1.62-10.22)
0.82 (0.26-1.89)

134
4
796
29

0.9 (0.79-1.02)
0.5 (0.19-1.04)
0.72 (0.67-0.76)
1.1 (0.89-1.33)

11
0
41
2

1.27 (0.7-2.08)
0.64 (0.42-0.93)
1.3 (0.19-4.25)

59
44
53
87
76
246

0.63 (0.33-1.07)
0.76 (0.66-0.86)
0.74 (0.54-1)
0.62 (0.56-0.69)
0.42 (0.39-0.46)
0.58 (0.46-0.73)

11
6
3
19
8
37

1.19 (0.6-2.07)
1.88 (0.95-3.29)
0.71 (0.04-3.2)
2.18 (0.73-4.91)
0.8 (0.3-1.69)
1.48 (1.03-2.04)

39
287
74
19
10

1.2 (0.94-1.51)
0.74 (0.69-0.78)
0.96 (0.77-1.2)
0.69 (0.51-0.90)
0.85 (0.49-1.38)

1
15
4
0
2

0.61 (0.21-1.35)
0.9 (0.55-1.36)
1.25 (0.1-4.94)
3.02 (0.26-12.01)

Note: AI/AN= American Indian/Alaska Native; PR= prevalence ratio; CI= confidence interval
Hypospadias restricted to males
Turner syndrome restricted to females
all aPRs are adjusted for maternal age; non-Hispanic Whites are the referent group

DISCUSSION
Overall, there were 34 statistically significant prevalence ratios. Among NH Asians,
23 (52%) defects showed a lower aPR and 3 (7%) had a higher aPR out of the 44 defects
studied. Furthermore, AI/ANs had 2 (5%) defects with lower aPRs and 6 (14%) with higher
aPRs out of the 44 defects studied. Based on the 44 birth defects and 2 independent
race/ethnic groups that were not NH White, by chance alone (p < 0.05) we would expect that
4 prevalence ratios would have been statistically significant (i.e., 44 x 2 x 0.05). Yet we
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observed 34 statistically significant prevalence ratios, which suggests that the results were
not a chance finding.
The aPRs calculated for AI/ANs were consistent with findings from the previous
national studies examining this population.15,16 Specifically, anotia/microtia and cleft lip with
cleft palate were both found to be significantly elevated among AI/ANs relative to NH
Whites in the current study and previous national studies. Furthermore, for the NH Asian
population, the previous national study found that the majority of birth defects studied (16
out of 27, or 59%) had a significantly lower aPR. There were 11 defects that were found to
be significant in both the previous and current studies, these defects include: spina bifida
without anencephalus, anotia/microtia, common truncus, aortic valve stenosis, hypoplastic
left heart syndrome, coarctation of the aorta, esophageal atresia, hypospadias, omphalocele,
limb deficiencies, and trisomy 21. For defects that were significant in the previous study but
were not in the current one, perhaps this is due to the smaller sample size and decreased
power as analyses were conducted using data from only Texas rather pooled data from 12
states.
The lower prevalence rates observed for over half of the studied defects among the
NH Asian population may be explained by various sociodemographic predictors for health.
According to data from the National Vital Statistics System, compared to all U.S. mothers,
NH Asian mothers were less likely to be teenagers and receive food prenatally via the
Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) and were
more likely to be 30 years or older, be married, and have higher educational attainment.20
These measures may be indicators of socioeconomic status, suggesting that NH Asian
16

mothers may have better access to prenatal care or are less exposed to risk factors that may
cause birth defects. Furthermore, in the U.S. in 2016, 82.7% of NH Asian mothers were
foreign-born.20 Therefore it is possible that the lower prevalence observed may be due to the
“healthy immigrant effect”.21 Studies have found that foreign-born individuals tend to have
better health outcomes compared to those who are U.S.-born. Immigrants are generally less
likely to have cardiovascular disease, obesity, mental disorders, certain cancers, and low birth
weight babies.21
This study had several limitations. Because the analyses were conducted on rare
outcomes (biliary atresia, holoprosencephaly, etc.) and among minority groups, some aPRs
were calculated based on cell sizes with 5 cases or less. This was true for 20 defects for
AI/ANs and 1 defect for NH Asians. This results in imprecise estimates, larger confidence
intervals, and weaker associations. However, it is still important for this data to be shown
because these two race/ethnic groups have been historically understudied due to small sample
sizes. The small numbers also disabled us from adjusting for additional covariates and to
further separate NH Asians into specific subgroups (e.g., Vietnamese, Chinese, etc.) and
AI/ANs into specific tribes (e.g., Cherokee, Navajo, etc.).
Despite the limitations, this study had several strengths. By using Texas data over
many years, there was a large enough birth population to be able to make statistical
inferences on the prevalence of selected birth defects for these lesser studied groups.
Additionally, the current dataset included a more recent time period and a wider range of
birth defects than the data used in the Canfield or Marengo study.15,16 The additional birth
defects in the current study were: holoprosencephaly, anophthalmia/microphthalmia, atrial
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septal defect, pulmonary valve atresia and stenosis, tricuspid valve atresia and stenosis,
Ebstein’s anomaly, hypoplastic left heart syndrome, total anomalous pulmonary venous
connection, single ventricle, interrupted aortic arch, choanal atresia, biliary atresia, small
intestinal atresia/stenosis, renal agenesis/hypoplasia, bladder exstrophy, congenital posterior
urethral valves, craniosynostosis, clubfoot, Turner syndrome, and deletion 22q11.2.
Although the population was smaller relative to national studies, the smaller size
allowed the free text variable of race/ethnicity description to be further assessed, reclassified,
and corrected. Specifically, we reclassified individuals in the NH and Hispanic “Other”
race/ethnic group. Through these additional data cleaning steps, we identified 13 additional
AI/AN cases, 306 additional AI/AN livebirths, 206 additional NH Asian cases, and 4,614
additional NH Asian livebirths, adding power to analysis.

CONCLUSION
This study examined the association between understudied race/ethnicity and a wide
range of birth defects within Texas using the most current data available. We found a number
of birth defects with statistically significantly higher or lower prevalence ratios in NH Asians
and AI/ANs, including some showing strong associations. Future research should explore
additional covariates that may impact the prevalence of birth defects such as maternal parity,
maternal and paternal education, paternal race/ethnicity, infant sex, smoking, and diabetes,
where there are sufficient numbers. Additionally, NH Asians should be stratified into
mothers’ specific countries of origin or nativity (U.S.-born vs. foreign-born) to determine
impact of country of origin or nativity on prevalence. Additionally, where data are sufficient,
18

birth defects should be separated into isolated cases, vs. those co-occurring with other birth
defects or chromosomal or syndromic conditions. Defects with higher prevalence among
AI/ANs warrants additional research within larger populations.
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